Venous Thromboembolism in Primary Pancreatic Tumour Resection (PaTR-VTE)

  • STATUS
    Recruiting
  • participants needed
    64
  • sponsor
    University of Thessaly
Send
Updated on 24 November 2025
See if I qualify

Summary

This study will evaluate the development of venous thromboembolism (VTE) and possible determinants in patients with primary pancreatic cancer undergoing pancreatic cancer resection.

Description

Cancer associated thrombosis (CAT) is the second cause of death, in oncologic patients after tumour progression itself. Patients suffering from malignancies are at increased risk for both venous (4-20%) and arterial (2-5%) thrombotic events. Moreover, cancer is one of the most important acquired risk factors for the development of venous thromboembolism (VTE).

Pancreatic cancer is the fourth most deadly cancer world-widely and has been recognised as the most prothrombotic malignancy, with a reported incidence of VTE (8-18%), followed by renal and ovarian cancer (VTE 5.6%). Although the exact pathophysiological mechanisms are still poorly understood it seems that pancreatic cancer induces a prothrombotic and hypercoagulable state.

Aims

  • To evaluate the predictive value of preoperatively or early postoperatively obtained NLR, in patients with primary pancreatic cancer undergoing pancreatic cancer resection, for VTE up to the 30rd postoperative day
  • To evaluate the predictive value of preoperatively or early postoperatively obtained coagulation biomarkers/parameters, in patients with primary pancreatic cancer undergoing pancreatic cancer resection, for VTE up to the 30rd postoperative day
  • To evaluate the incidence of VTE in patients with primary pancreatic cancer undergoing pancreatic cancer resection
  • To assess the perioperative coagulation status of patients with primary pancreatic cancer undergoing pancreatic cancer resection
  • To evaluate any possible determinant or predictive factor for VTE among the coagulation parameters or patients' baseline characteristics

Details
Condition Venous Thromboembolism, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
Age 18years or above
Clinical Study IdentifierNCT05964621
SponsorUniversity of Thessaly
Last Modified on24 November 2025

Eligibility

 Yes No Not Sure

Inclusion Criteria

Consecutive pancreatic cancer patients undergoing pancreatic cancer resection in University Hospital of Larissa, after informed consent will be included

Exclusion Criteria

Refuse to participate
Previous thromboembolic event < 6 months prior to the operation
History of inherited or acquired bleeding disorder
ASA PS > 3
Concomitant presence of a second primary malignancy
Unresectable pancreatic cancer
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.